Berri to Asharq Al-Awsat: US Draft Proposal on Maritime Deal is ‘Positive’

US Ambassador to Lebanon Dorothy Shea (L) presents a letter to Lebanon's Parliament Speaker Nabih Berri (R) during their meeting at Berri's house in Beirut, Lebanon, 01 October 2022. EPA/WAEL HAMZEH
US Ambassador to Lebanon Dorothy Shea (L) presents a letter to Lebanon's Parliament Speaker Nabih Berri (R) during their meeting at Berri's house in Beirut, Lebanon, 01 October 2022. EPA/WAEL HAMZEH
TT

Berri to Asharq Al-Awsat: US Draft Proposal on Maritime Deal is ‘Positive’

US Ambassador to Lebanon Dorothy Shea (L) presents a letter to Lebanon's Parliament Speaker Nabih Berri (R) during their meeting at Berri's house in Beirut, Lebanon, 01 October 2022. EPA/WAEL HAMZEH
US Ambassador to Lebanon Dorothy Shea (L) presents a letter to Lebanon's Parliament Speaker Nabih Berri (R) during their meeting at Berri's house in Beirut, Lebanon, 01 October 2022. EPA/WAEL HAMZEH

US mediator Amos Hochstein has presented a written proposal for maritime boundary demarcation between Lebanon and Israel that establishes a qualitative breakthrough in the indirect negotiations between the two enemy states.

Lebanese Parliament Speaker Nabih Berri had labeled the proposal as a “draft deal” that meets Lebanon's demands.

“In principle, it meets Lebanese demands which refuse to give any effect to the maritime agreement on land borders,” Berri told Asharq Al-Awsat minutes after US Ambassador Dorothy Shea left his office.

A Lebanese committee including Deputy Parliament Speaker Elias Bou Saab, Director General of the Presidency Antoine Choucair, Parliament Speaker Advisor Ali Hamdan, and a technical army officer will meet in the coming 24 hours, Asharq Al-Awsat learned.

The committee will review the notes of Lebanese officials regarding the proposal and present amendments if the need arises.

Bou Saab, who is also Lebanon’s lead negotiator on the maritime border dispute with Israel, said that the atmosphere is more “positive” than ever.

“We are waiting for the committee meeting, which will be held after translating the agreement into Arabic, to put forward the Lebanese comments on it,” he told Asharq Al-Awsat, affirming that amendments will be made to the draft proposal.

“The US ambassador confirmed that the text is not final, and therefore subject to amendment,” Bou Saab revealed. However, the deputy parliament speaker stressed that the amendments to be presented by Lebanon will be “extraneous.”

Bou Saab highlighted that the proposal was mainly “agreed upon,” but stressed that it still needed technical and legal translation.

According to him, the agreement proposal represents the yield of a “unified Lebanese position.”

“Things seem very positive,” Shea commented after meeting Berri, who when asked if the development is any success said it was good for a start.

“The 10-page agreement is written in English and requires studying before presenting a final response,” explained Berri, pointing out that he, President Michel Aoun and Prime Minister Najib Mikati were reviewing the proposal with their aides.

After revision, Aoun, Berri and Mikati will consult with one another before giving an answer to the US-brokered deal.

If all goes well, Lebanon and Israel will sign the deal in the border city of Naqoura, Berri asserted, as this is per the framework agreement he reached with the US last year.

Sources familiar with Shea’s meetings told Asharq Al-Awsat that a tripartite meeting will take place in the middle of next week to agree on the official Lebanese response.

The same sources revealed that the US wants a deal to be concluded as soon as possible, i.e. within the next two weeks.

Shea had handed each of Aoun, Berri and Mikati a copy of Hochstein’s written proposal.

The Lebanese presidency had affirmed that Aoun met with Shea and received the written proposal from Hochstein for the demarcation of the maritime border with Israel.

Aoun then contacted Berri and Mikati for a consultation on the US proposal. He discussed with the two “how to move forward to provide a Lebanese response as soon as possible.”

This is the first time since the start of indirect negotiations between Lebanon and Israel two years ago that a written letter has been submitted by the US regarding the demarcation of maritime borders.

After a months-long stalemate, the file gained some momentum after a production and storage vessel arrived near the disputed Karish field last June.

Indirect negotiations between Lebanon and Israel started in 2020. They stopped in May 2021.

Originally, talks were supposed to discuss an 860-square-kilometer disputed area which is defined by borders known as “line 23,” according to a map sent by Lebanon to the United Nations in 2011.

However, Lebanon later considered that the map was based on wrong estimates and demanded that an additional 1,430 square kilometers be considered, including parts of the Karish field.

After the arrival of the gas extraction platform off the Israeli coast, Lebanon called on Hochstein to resume negotiations.

The Mediterranean nation also presented a new offer for demarcating borders without including the Karish gas field. It, however, included the Qana gas field.

Reaching an agreement would facilitate the exploration of oil resources within Lebanon’s territorial waters.

Lebanese authorities are counting on the presence of oil reserves as this could help their country to overcome a catastrophic economic collapse that’s been going on for nearly three years.

Hezbollah leader Hassan Nasrallah lauded the US-mediated draft proposal to resolve a maritime border dispute between Israel and Lebanon as “a very important step.”

In a change of tone, Nasrallah said that Lebanon’s state officials are the ones to decide on the proposal. He had hinted at escalation several times previously.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.